Atara Biotherapeutics, Inc.

Introduction

This page provides a comprehensive analysis of the known insider trading history of John Mcgrath. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate John Mcgrath has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ATRA / Atara Biotherapeutics, Inc. EVP & Chief Financial Officer 88,762
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by John Mcgrath. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ATRA / Atara Biotherapeutics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ATRA / Atara Biotherapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ATRA / Atara Biotherapeutics, Inc. Insider Trades
Insider Sales ATRA / Atara Biotherapeutics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ATRA / Atara Biotherapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ATRA / Atara Biotherapeutics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by John Mcgrath as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2018-03-20 2018-03-20 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -3,000 88,762 -3.27 38.83 -116,490 3,446,628
2018-03-20 2018-03-19 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -3,000 91,762 -3.17 41.99 -125,970 3,853,086
2018-02-20 2018-02-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,500 94,762 -2.57 48.08 -120,200 4,556,157
2018-02-20 2018-02-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -4,000 97,262 -3.95 46.93 -187,720 4,564,506
2018-02-20 2018-02-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -5,132 0 -100.00
2018-02-20 2018-02-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
F - Taxes -2,926 101,262 -2.81 47.05 -137,668 4,764,377
2018-02-20 2018-02-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 5,132 104,188 5.18
2018-02-20 2018-02-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -6,500 99,056 -6.16 46.77 -304,005 4,632,849
2018-02-12 2018-02-09 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
F - Taxes -4,819 105,556 -4.37 41.70 -200,952 4,401,685
2018-02-08 2018-02-06 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 50,000 50,000
2018-02-08 2018-02-06 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
F - Taxes -4,279 110,375 -3.73 35.80 -153,188 3,951,425
2018-02-08 2018-02-06 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 25,000 114,654 27.88
2018-01-12 2018-01-12 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise X -30,000 10,000 -75.00
2018-01-12 2018-01-12 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -30,000 89,654 -25.07 25.00 -750,000 2,241,350
2018-01-12 2018-01-12 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -3,500 119,654 -2.84 22.32 -78,120 2,670,677
2018-01-12 2018-01-12 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise X 30,000 123,154 32.20 11.00 330,000 1,354,694
2018-01-12 2018-01-11 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -3,500 93,154 -3.62 20.77 -72,695 1,934,809
2018-01-02 2017-12-29 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -32,000 96,654 -24.87 20.00 -640,000 1,933,080
2017-11-17 2017-11-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -7,697 5,132 -60.00
2017-11-17 2017-11-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,697 128,654 6.36
2017-08-17 2017-08-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,100 120,957 -1.71 14.39 -30,219 1,740,571
2017-08-17 2017-08-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -7,697 12,829 -37.50
2017-08-17 2017-08-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,100 123,057 -1.68 14.23 -29,883 1,751,101
2017-08-17 2017-08-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,697 125,157 6.55
2017-05-17 2017-05-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,000 117,460 -1.67 15.27 -30,540 1,793,614
2017-05-17 2017-05-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -7,698 20,526 -27.27
2017-05-17 2017-05-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -935 0 -100.00
2017-05-17 2017-05-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,000 119,460 -1.65 14.95 -29,900 1,785,927
2017-05-17 2017-05-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,698 121,460 6.77
2017-05-17 2017-05-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 935 113,762 0.83
2017-03-23 2017-03-23 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -6,500 112,827 -5.45 21.08 -137,020 2,378,393
2017-03-23 2017-03-22 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -7,500 119,327 -5.91 20.27 -152,025 2,418,758
2017-03-10 2017-03-10 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -24,000 126,827 -15.91 20.00 -480,000 2,536,540
2017-02-22 2017-02-21 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -9,000 150,827 -5.63 15.14 -136,260 2,283,521
2017-02-16 2017-02-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -7,697 28,224 -21.43
2017-02-16 2017-02-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -2,804 935 -74.99
2017-02-16 2017-02-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,697 159,827 5.06
2017-02-16 2017-02-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 2,804 152,130 1.88
2017-02-08 2017-02-06 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 49,500 149,326 49.59
2016-11-17 2016-11-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -7,698 35,921 -17.65
2016-11-17 2016-11-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -2,805 3,739 -42.86
2016-11-17 2016-11-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,698 99,826 8.36
2016-11-17 2016-11-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 2,805 92,128 3.14
2016-11-14 2016-11-11 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,500 89,323 -2.72 19.37 -48,425 1,730,187
2016-11-14 2016-11-10 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,500 91,823 -2.65 20.30 -50,750 1,864,007
2016-10-13 2016-10-12 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,500 94,323 -2.58 16.41 -41,025 1,547,840
2016-10-13 2016-10-11 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -2,500 96,823 -2.52 18.52 -46,300 1,793,162
2016-08-17 2016-08-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -7,697 43,619 -15.00
2016-08-17 2016-08-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -2,804 6,544 -30.00
2016-08-17 2016-08-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,697 99,323 8.40
2016-08-17 2016-08-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 2,804 91,626 3.16
2016-05-18 2016-05-16 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -7,698 51,316 -13.04
2016-05-18 2016-05-16 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -2,805 9,348 -23.08
2016-05-18 2016-05-16 4 ATRA Atara Biotherapeutics, Inc.
Commono Stock
S - Sale X -5,395 88,822 -5.73 15.77 -85,079 1,400,723
2016-05-18 2016-05-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,698 94,217 8.90
2016-05-18 2016-05-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 2,805 86,519 3.35
2016-02-18 2016-02-16 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -7,697 59,014 -11.54
2016-02-18 2016-02-16 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -2,804 12,153 -18.75
2016-02-18 2016-02-16 4 ATRA Atara Biotherapeutics, Inc.
Commono Stock
S - Sale X -6,000 83,714 -6.69 15.49 -92,940 1,296,730
2016-02-18 2016-02-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,697 89,714 9.38
2016-02-18 2016-02-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 2,804 82,017 3.54
2016-02-11 2016-02-09 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 42,857 79,213 117.88
2015-12-21 2015-12-17 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
A - Award 65,000 65,000
2015-12-01 2015-11-30 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -6,000 36,356 -14.17 40.00 -240,000 1,454,240
2015-11-18 2015-11-16 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -7,697 66,711 -10.34
2015-11-18 2015-11-16 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -2,805 14,957 -15.79
2015-11-18 2015-11-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,697 42,356 22.21
2015-11-18 2015-11-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 2,805 34,659 8.81
2015-08-19 2015-08-18 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -6,000 31,854 -15.85 49.38 -296,280 1,572,951
2015-08-19 2015-08-17 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -7,698 74,408 -9.38
2015-08-19 2015-08-17 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
M - Exercise -2,804 17,762 -13.63
2015-08-19 2015-08-17 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 7,698 37,854 25.53
2015-08-19 2015-08-17 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 2,804 30,156 10.25
2015-06-16 2015-06-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -10,000 27,352 -26.77 50.00 -500,000 1,367,600
2015-06-01 2015-05-29 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
S - Sale X -10,000 37,352 -21.12 40.00 -400,000 1,494,080
2015-05-19 2015-05-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
A - Award 41,052 82,106 100.00
2015-05-19 2015-05-15 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Units
A - Award 24,305 20,566 -650.04
2015-05-19 2015-05-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
F - Taxes -30,405 47,352 -39.10 37.30 -1,134,106 1,766,230
2015-05-19 2015-05-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 41,052 77,757 111.84
2015-05-19 2015-05-15 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
M - Exercise 24,305 36,705 196.01
2015-01-21 2015-01-16 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise 41,333 41,333
2015-01-21 2015-01-16 4 ATRA Atara Biotherapeutics, Inc.
Common Stock
A - Award 12,400 12,400
2014-10-23 2014-10-21 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Unit
A - Award 123,158 123,158
2014-10-23 2014-10-21 4 ATRA Atara Biotherapeutics, Inc.
Restricted Stock Unit
A - Award 44,871 44,871
2014-10-16 2014-10-15 4 ATRA Atara Biotherapeutics, Inc.
Employee Stock Option (Right to Buy)
M - Exercise 40,000 40,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)